Provided by Tiger Fintech (Singapore) Pte. Ltd.

Imunon, Inc.

7.00
-0.5465-7.24%
Post-market: 7.290.2899+4.14%19:56 EDT
Volume:286.09K
Turnover:1.97M
Market Cap:14.85M
PE:-0.34
High:7.66
Open:7.65
Low:6.51
Close:7.55
Loading ...

Imunon, Inc. Advances DNA Vaccine Study for COVID-19 Variants

TIPRANKS
·
15 hours ago

Imunon Inc. Announces 1-for-15 Reverse Stock Split Effective July 25, 2025

Reuters
·
23 Jul

Imunon Announces Reverse Stock Split

THOMSON REUTERS
·
23 Jul

Imunon Inc. Files Prospectus to Register Additional $4.5 Million in Common Stock for At the Market Offering

Reuters
·
22 Jul

Imunon Inc. Receives Nasdaq Delisting Notice Over Non-Compliance With Minimum Bid Price Requirement

Reuters
·
15 Jul

Imunon Inc. Conducted Annual Stockholders Meeting

Reuters
·
12 Jul

Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment

TIPRANKS
·
09 Jul

Imunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian Cancer

TIPRANKS
·
04 Jul

Imunon Submits Compliance Plan to Nasdaq; Shares Rise

MT Newswires Live
·
30 Jun

BRIEF-Imunon Submits Plan In Consultation With Exchange To Ensure Compliance With Nasdaq's Listing Requirement, Anticipates Additional Compliance Period

Reuters
·
30 Jun

Imunon presents data from its Phase 2 OVATION 2 study of IMNN-001

TIPRANKS
·
18 Jun

Imunon Inc. Files Initial Statement of Beneficial Ownership for CFO Kimberly Bragg

Reuters
·
18 Jun

Imunon announces abstract on Phase 1 proof-of-concept trial of IMNN-101

TIPRANKS
·
17 Jun

BRIEF-Imunon - Terminates CFO David Gaiero's Service Agreement

Reuters
·
14 Jun

Imunon Inc. Appoints Kimberly Graper as Interim Chief Financial Officer Following Termination of Consulting Agreement with David Gaiero

Reuters
·
14 Jun

Imunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement

Reuters
·
10 Jun

Imunon Inc. Presents Updated Survival Analysis from OVATION-2 Trial on Safety and Efficacy of IMNN-001 in Advanced EOC Patients

Reuters
·
03 Jun

Imunon announces data from Phase 2 OVATION 2 study on IMNN-001

TIPRANKS
·
03 Jun

Imunon files to sell 22.03M shares of common stock for holders

TIPRANKS
·
31 May

Imunon Inc. Faces Nasdaq Delisting After Failing to Meet Minimum Bid Price Requirement

Reuters
·
31 May